← Open Payments lookup

CHERYL BAYENS: Open Payments

NPI 1679967673 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,993 in 139 payments from 19 companies in 2025. Trend: 2023 $3,029 · 2024 $3,126 · 2025 $2,993

Food & beverage: $2,993
CompanyPaymentsAmount
ABBVIE INC.43$945
Takeda Pharmaceuticals U.S.A., Inc.27$503
GENZYME CORPORATION8$357
Madrigal Pharmaceuticals13$246
Aimmune Therapeutics, Inc.9$157
Regeneron Healthcare Solutions, Inc.6$145
QOL Medical, LLC5$106
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$87
Ipsen Biopharmaceuticals, Inc3$63
Ardelyx, Inc.4$60

Products named: DUPIXENT, RINVOQ, ENTYVIO, REZDIFFRA, MAVYRET, ZENPEP, CREON, Sucraid.

Industry payments across MO — which companies pay providers there.